Aerotel Medical System Form an Alliance with Italian Leading Telemedicine Services Provider Telbios

TelbiosTelbios, the leading telemedicine services provider in Italy, has signed an exclusivity agreement with Aerotel Medical System, world leader in manufacturing of medical devices and software platforms for telemedicine and Home Care services, for exclusive marketing and distribution of Aerotel innovative products in the Italian market.

AerotelThe agreement with Aerotel expands the range of telemedicine and home care services offered by Telbios, which includes Tele-assistance, Tele-cardiology, and Tele-radiology services. Health organizations such as hospitals, private and public healthcare institutions can now offer their patients a simple and efficient means to monitor the state of their health.

"The agreement with Aerotel is important since it gives us access to devices and technologies that are state of the art and that complete Telbios’s range of services offered," says Leopold Genovesi, CEO of Telbios.

Aerotel's devices such as EKG machines allow the patients to self measure the cardiologic parameters and send them, in short time, via telephone or GSM mobile phone handset, from any location to the call center. The transmitted information can be instantly interpreted by the team of cardiologists of San Raffaele Scientific Institute in Milan working within Telbios Telemedicine Service Center on a 24 hours call basis and immediately sent to the attending GP of the patient.

"Thanks to this technology the chronically ill patients can now avail of those technologies and are offered the possibility to be monitored without leaving the comfort of their home or while travelling and still follow a tight treatment protocol that results in the benefit of their quality of life," conclude Genovesi.

"Telemedicine is a growing market all over the globe and in Italy we can also see a very positive growth," says David Rubin, President & CEO of Aerotel Medical Systems."Having Telbios as a business partner will allow us both to develop dedicated solutions to the growing Italian market."

Monitoring the chronically ill patients can be considered as an emergency on a national level: in Italy there are over 2.5 million diabetic patients, over 4 million patients suffering for respiratory dysfunction, one million of patients suffering form chronic heart failure and the number of patients under anticoagulation treatment exceeds one million. Patients with two or more chronic diseases are the 19.4% of the population.

Telemedicine is the most suitable remote follow up method for the cited pathologies. Telemedicine reduces the unnecessary hospitalizations and reduces waiting lists for medical treatment with a significant saving factor on economical resources.

TELBIOS S.p.A.
Ufficio Stampa
Danilo Magliano
Tel .: +39 02 26433759
Mobile: +39 3357 563583
Web: www.telbios.it
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerotel
Hazoref st. 5, Holon 58856, Israel
Tel.: +972 3 559 3222
Fax: +972 3 559 6111
Web: www.aerotel.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Telbios
Telbios is the Italian company leader for Telemedicine services and networks in civil and military health care structures, and for Home Care assistance, proposing services and customer oriented solutions.

Telbios features his services thanks to the assistance supplied by Telemedicine Service Center (TSC) where 24 h a day technic specialist operators and specialist phisicians are on hand for customer clinic data and diagnostic images recipt, management, archiving, monitoring and reporting. CST ensures a protect data access to information about single patient and enables the web clinic data sharing, with emergency intervention activity at every time.
For more information about Telbios, please visit Telbios website at www.telbios.com

About Aerotel Medical Systems
Aerotel Medical Systems is a world leader in cost-effective, high quality, user-friendly, medical diagnostic systems and devices for the home care, eHealth and Telemedicine markets. The company provides a complete disease management package, including transtelephonic Portable devices designed for a variety of remote diagnostic, and monitoring applications; a hardware and software platform; plus phone and web-based software.

Established in 1985, Aerotel has implemented its solutions in the USA, Europe, India, China, Australia, South America and many other countries worldwide.Frost & Sullivan has recently named Aerotel as "Company of the year" for the European telemedicine market. Aerotel products are CE marked and FDA cleared for marketing in the US with the intention to be used by patients themselves. They are designed for simple use and are famous for their quality and reliability.
For more information about Aerotel, please visit Aerotel website at www.aerotel.com

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

New Medical AI Tool Identifies more Case…

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can...

NIH-Developed AI Algorithm Successfully …

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

MEDICA 2024 and COMPAMED 2024: Medical T…

11 - 14 November 2024, Düsseldorf, Germany. "Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto...